Core Area
Research
Strategic Area
Industry and health sector engagement to drive impact and entrepreneurship and to enrich learner and faculty experience
Goal Status
In Progress
Objectives
- Launch of therapy area or researcher specific communication tools.
- Develop a platform for PharmSci ventures to advertise on e@ubc for recruitment and collaboration (2024/25).
Achieved Goals
- Launched Pharmaceutical Research Network (PRN) events to enable Faculty members to connect and network (March 2023).
- SPIIF fund approved project to support networking opportunities and promotion for researchers (May 2023).
- Launched UBC Pharm Sci Innovative Thinkers Webinar Series (Sep 2023).
- Supported workshop for grant and industry partnership with faculty principal investigators, including funding mechanisms and processes/support, delivered by MITACS (Feb 2023); entrepreneur-in-residence to support implementation.
- Promoted and supported electronic Health Technology Assessment (eHTA) and other research and development activities within Nanomedicines Innovation Network (NMIN) community (initiated summer 2023 and ongoing).
- Supported launch of e@ubc Venture Founder incubator program (2024).
- Highlighted a number of our faculty members who have received major research awards: Dr. Ly Vu, received a Tier 2 Canada Research Chair in RNA biology in hematological malignancies (2023), and the V Foundation for Cancer Research, Women Scientists Innovation Award for Cancer Research (V Scholar) (2023); Dr. Karla Williams renewed as Tier 2 Canada Research Chair in Oncology (2024); Dr. Brian Rodrigues awarded the 2023 Association of Faculties of Pharmacy of Canada (AFPC) /Pfizer Research Career Award; Dr. Jacquelyn Cragg awarded the 2024 Association of Faculties of Pharmacy of Canada (AFPC) New Investigator Research Award; Dr. Ricky Turgeon awarded a 2023 Michael Smith Health Research BC Health Professional-Investigator Award; Dr. Simon Wisnovsky awarded a 2023 Michael Smith Health Research BC Scholar Award.